BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:The second edition of the industry-led Wet AMD and DME Drug De
 velopment Summit arrives in Boston to give you comprehensive insight into
  the current and emerging angiogenesis- inflammatory-directed and anti-fi
 brotic drug development programs for these three ophthalmic conditions – 
 neovascular age-related macular degeneration (wet AMD)\, diabetic retinop
 athy (DR) and diabetic macular edema (DME).\n\nJoin this dedicated indust
 ry forum to network online and learn from senior leaders of discovery\, t
 ranslational sciences\, and clinical development from the likes of Roche\
 , Genentech\, Novartis\, Apellis\, Outlook Therapeutics and more\, to add
 ress the specific challenges for the biopharmaceutical and biotechnology 
 in its efforts to bring long-lasting treatments which reduce clinical bur
 den and can be commercialized to become the new standard-of-care in this 
 vast ophthalmology indication.\n\nNavigate across 3 jam-packed days inclu
 ding two interactive workshops exploring the optimization of administrati
 on techniques and viral and non-viral vectors to deliver safe and durable
  anti-angiogenic therapies to the eye and developing preclinical and tran
 slational models to predict human disease and efficacy of a drug.\n\nEarl
 ybird and group booking discounts available\, visit the website for more 
 information.\n
DTEND:20220407T170000
DTSTAMP:20260512T223116Z
DTSTART:20220405T080000
LOCATION:Embassy Suites by Hilton Boston at Logan Airport\, 207\, Porter S
 treet\, Boston\, Massachusetts\, 02128\,
SEQUENCE:0
SUMMARY:The second edition of the industry-led Wet AMD and DME Drug Develo
 pment Summit arrives in Boston to give you comprehensive insight into the
  current...
UID:19a5c82d-bc65-4c71-ae1d-0df87a439f37
END:VEVENT
END:VCALENDAR